CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 1,500 shares at an average $219.87 ($329,810)
- 4 Planned sale Director sold 2,964 shares at $216.78 ($642,536)
- 4 Planned sale Director sold 3,150 shares at an average $211.14 ($665,087)
- 4 Planned sale EXECUTIVE CHAIRMAN sold 100,000 shares at an average $214.47 ($21,447,308)
- 8-K/A Event Executive or director change
- 8-K Event Executive or director change · Shareholder vote results
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 11,000 shares at an average $217.21 ($2,389,328)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale CEO AND PRESIDENT sold 41,124 shares at an average $221.03 ($9,089,776)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 144 Insider Sale of Securities
- 4 Planned sale PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $218.43 ($655,295)
- 4 Grant or award Director acquired 2,124 shares (grant or award)
- 4 Open-market sale Director sold 78,000 shares at an average $220.31 ($17,184,092)
- 144 Insider Sale of Securities
Page 8 of 94 · 1,862 filings